Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

December 21, 2024

Study Completion Date

December 28, 2024

Conditions
Hypoxic Events
Interventions
DEVICE

FDA approved pulse oximeter and DOVE device prototype

The objective is to assess reasonable detection of hypoxic episodes

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER